Cellular senescence: From physiology to pathology

Nature Reviews Molecular Cell Biology

Volumn 15, Issue 7, 2014, Pages 482-496

  Muñoz Espín, Daniel ^a   Serrano, Manuel ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; REACTIVE OXYGEN METABOLITE;

AORTA ANEURYSM; APOPTOSIS; ATHEROSCLEROSIS; BRAIN; BRAIN ARTERY ANEURYSM; BRANCHIAL ARCH; CARTILAGE CELL; CATARACT; CELL AGING; CELL STRESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DNA DAMAGE; DNA REPLICATION; EMBRYO DEVELOPMENT; ENDOLYMPHATIC SAC; FINGER; GALLBLADDER; GENE ACTIVATION; GENE EXPRESSION; GLAUCOMA; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTESTINE; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; LUNG FIBROSIS; MEGAKARYOCYTE; MESONEPHROS; MOUTH DISEASE; MUCOSA INFLAMMATION; NEOPLASM; NEURAL TUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ONCOGENE; ORAL MUCOSITIS; OSTEOARTHRITIS; OXIDATIVE STRESS; PARKINSON DISEASE; PHAGOCYTOSIS; PLACENTA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PULMONARY HYPERTENSION; RETINA MACULA DEGENERATION; REVIEW; RHOMBENCEPHALON; SARCOPENIA; STERNUM; SYNCYTIOTROPHOBLAST; TELOMERE SHORTENING; VIBRISSA; VON HIPPEL LINDAU DISEASE; WOUND HEALING;

AGING; ANIMALS; CELL AGING; HUMANS; MICE; NEOPLASMS;

EID: 84904702784     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3823     Document Type: Review

References (186)

1. Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961
2. Campisi, J. & d'Adda di Fagagna, F. Cellular senescence: When bad things happen to good cells. Nature Rev. Mol. Cell Biol. 8, 729-740 (2007
3. Collado, M., Blasco, M. A. & Serrano, M. Cellular senescence in cancer and aging. Cell 130, 223-233 (2007
4. Collado, M. & Serrano, M. Senescence in tumours: Evidence from mice and humans. Nature Rev. Cancer 10, 51-57 (2010
5. Gorgoulis, V. G. & Halazonetis, T. D. Oncogene-induced senescence: The bright and dark side of the response. Curr. Opin. Cell Biol. 22, 816-827 (2010
6. van Deursen, J. M. The role of senescent cells in ageing. Nature 509, 439-446 (2014
7. Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev. 24, 2463-2479 (2010
8. Salama, R., Sadaie, M., Hoare, M. & Narita, M. Cellular senescence and its effector programs. Genes Dev. 28, 99-114 (2014
9. Chicas, A. et al. Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17, 376-387 (2010
10. Galluzzi, L. et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19, 107-120 (2012
11. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990
12. Parrinello, S. et al. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nature Cell Biol. 5, 741-747 (2003
13. Passos, J. F. et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 6, 347 (2010
14. Fumagalli, M. et al. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nature Cell Biol. 14, 355-365 (2012
15. Kim, W. Y. & Sharpless, N. E. The regulation of INK4/ ARF in cancer and aging. Cell 127, 265-275 (2006
16. Gil, J. & Peters, G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: All for one or one for all. Nature Rev. Mol. Cell Biol. 7, 667-677 (2006
17. Krishnamurthy, J. et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114, 1299-1307 (2004
18. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (1999
19. Bracken, A. P. et al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev. 21, 525-530 (2007
20. Velimezi, G. et al. Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer. Nature Cell Biol. 15, 967-977 (2013
21. Evangelou, K. et al. The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis. Cell Death Differ. 20, 1485-1497 (2013
22. Passos, J. F., Simillion, C., Hallinan, J., Wipat, A. & von Zglinicki, T. Cellular senescence: Unravelling complexity. Age 31, 353-363 (2009
23. Debacq-Chainiaux, F., Boilan, E., Dedessus Le Moutier, J., Weemaels, G. & Toussaint, O. p38(MAPK). in the senescence of human and murine fibroblasts. Adv. Exp. Med. Biol. 694, 126-137 (2010
24. Chen, Q., Fischer, A., Reagan, J. D., Yan, L. J. & Ames, B. N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl Acad. Sci. USA 92, 4337-4341 (1995
25. Lee, A. C. et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274, 7936-7940 (1999
26. Macip, S. et al. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 21, 2180-2188 (2002
27. Sun, P. et al. PRAK is essential for ras-induced senescence and tumor suppression. Cell 128, 295-308 (2007
28. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997
29. Alimonti, A. et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120, 681-693 (2010
30. Courtois-Cox, S. et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10, 459-472 (2006
31. Young, A. P. et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nature Cell Biol. 10, 361-369 (2008
32. Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637 (2006
33. Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642 (2006
34. Efeyan, A. & Serrano, M. p53: Guardian of the genome and policeman of the oncogenes. Cell Cycle 6, 1006-1010 (2007
35. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008
36. Evan, G. I. & d'Adda di Fagagna, F. Cellular senescence: Hot or what? Curr. Opin. Genet. Dev. 19, 25-31 (2009
37. Campisi, J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705 (2013
38. Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-Associated secretory phenotype: The dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118 (2010
39. Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nature Rev. Cancer 9, 81-94 (2009
40. Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018 (2008
41. Coppe, J. P. et al. Senescence-Associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868 (2008
42. Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031 (2008
43. Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660 (2007
44. Hoenicke, L. & Zender, L. Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies. Carcinogenesis 33, 1123-1126 (2012
45. Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nature Cell Biol. 15, 978-990 (2013
46. Nelson, G. et al. A senescent cell bystander effect: Senescence-induced senescence. Aging Cell 11, 345-349 (2012
47. Hubackova, S., Krejcikova, K., Bartek, J. & Hodny, Z. IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine 'bystander senescence'. Aging 4, 932-951 (2012)
48. Munoz-Espin, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104-1118 (2013
49. Storer, M. et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155, 1119-1130 (2013
50. Nacher, V. et al. The quail mesonephros: A new model for renal senescence? J. Vasc. Res. 43, 581-586 (2006
51. Huang, T. & Rivera-Perez, J. A. Senescence-Associated beta-galactosidase activity marks the visceral endoderm of mouse embryos but is not indicative of senescence. Genesis 52, 300-308 (2014
52. Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551 (2011
53. Fuchs, Y. & Steller, H. Programmed cell death in animal development and disease. Cell 147, 742-758 (2011
54. Lindsten, T. et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399 (2000
55. Ren, D. et al. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330, 1390-1393 (2010
56. Besancenot, R. et al. A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: Implications for physiological and pathological megakaryocytic proliferation. PLoS Biol. 8, e1000476 (2010
57. Chuprin, A. et al. Cell fusion induced by ERVWE1 or measles virus causes cellular senescence. Genes Dev. 27, 2356-2366 (2013
58. Ullah, Z., Lee, C. Y., Lilly, M. A. & DePamphilis, M. L. Developmentally programmed endoreduplication in animals. Cell Cycle 8, 1501-1509 (2009
59. Kopp, H. G., Hooper, A. T., Shmelkov, S. V. & Rafii, S. β-galactosidase staining on bone marrow. The osteoclast pitfall. Histol. Histopathol. 22, 971-976 (2007
60. Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661-665 (2007
61. Michaud, K. et al. Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts. Cancer Res. 70, 3228-3238 (2010
62. Thangavel, C. et al. Therapeutically activating RB: Reestablishing cell cycle control in endocrine therapy-resistant breast cancer. Endocr. Relat. Cancer 18, 333-345 (2011
63. Rader, J. et al. Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin. Cancer Res. 19, 6173-6182 (2013
64. Leonard, J. P. et al. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood 119, 4597-4607 (2012
65. Guha, M. Blockbuster dreams for Pfizer's CDK inhibitor. Nature Biotech. 31, 187 (2013
66. Dickson, M. A. et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-Amplified well-differentiated or dedifferentiated liposarcoma. J. Clin. Oncol. 31, 2024-2028 (2013
67. Sun, Y. et al. Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nature Med. 18, 1359-1368 (2012
68. Wiemann, S. U. et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935-942 (2002
69. Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667 (2008
70. Borkham-Kamphorst, E. et al. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-beta signaling. Biochim. Biophys. Acta 1843, 902-914 (2014
71. Kim, K. H., Chen, C. C., Monzon, R. I. & Lau, L. F. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol. Cell. Biol. 33, 2078-2090 (2013
72. Wolstein, J. M. et al. INK4a knockout mice exhibit increased fibrosis under normal conditions and in response to unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 299, F1486-1495 (2010
73. Ramakrishna, G. et al. Role of cellular senescence in hepatic wound healing and carcinogenesis. Eur. J. Cell Biol. 91, 739-747 (2012
74. Kong, X. et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56, 1150-1159 (2012
75. Klein, S. et al. Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats. Lab Invest. 92, 1440-1450 (2012
76. Jun, J. I. & Lau, L. F. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nature Cell Biol. 12, 676-685 (2010
77. Jun, J. I. & Lau, L. F. Cellular senescence controls fibrosis in wound healing. Aging 2, 627-631 (2010
78. Pitiyage, G. N. et al. Senescent mesenchymal cells accumulate in human fibrosis by a telomere-independent mechanism and ameliorate fibrosis through matrix metalloproteinases. J. Pathol. 223, 604-617 (2011
79. Naesens, M. Replicative senescence in kidney aging, renal disease, and renal transplantation. Discov. Med. 11, 65-75 (2011
80. Joosten, S. A. et al. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am. J. Pathol. 162, 1305-1312 (2003
81. Melk, A. Senescence of renal cells: Molecular basis and clinical implications. Nephrol. Dial Transplant 18, 2474-2478 (2003
82. Ding, G. et al. Tubular cell senescence and expression of TGF-β1 and p21(WAF1/CIP1). in tubulointerstitial fibrosis of aging rats. Exp. Mol. Pathol. 70, 43-53 (2001
83. Liu, J. et al. Accelerated senescence of renal tubular epithelial cells is associated with disease progression of patients with immunoglobulin A (IgA). nephropathy. Transl. Res. 159, 454-463 (2012
84. Verzola, D. et al. Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am. J. Physiol. Renal Physiol. 295, F1563-1573 (2008
85. Westhoff, J. H. et al. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 52, 123-129 (2008
86. Clements, M. E., Chaber, C. J., Ledbetter, S. R. & Zuk, A. Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS ONE 8, e70464 (2013
87. Dirocco, D. et al. CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. Am. J. Physiol. Renal Physiol. 306, F379-388 (2013
88. Braun, H. et al. Cellular senescence limits regenerative capacity and allograft survival. J. Am. Soc. Nephrol. 23, 1467-1473 (2012
89. Zhu, F. et al. Senescent cardiac fibroblast is critical for cardiac fibrosis after myocardial infarction. PLoS ONE 8, e74535 (2013
90. Erusalimsky, J. D. Vascular endothelial senescence: From mechanisms to pathophysiology. J. Appl. Physiol. 106, 326-332 (2009
91. Fyhrquist, F., Saijonmaa, O. & Strandberg, T. The roles of senescence and telomere shortening in cardiovascular disease. Nature Rev. Cardiol 10, 274-283 (2013
92. Wang, J. C. & Bennett, M. Aging and atherosclerosis: Mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 111, 245-259 (2012
93. Minamino, T. et al. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation 105, 1541-1544 (2002
94. Holdt, L. M. et al. Expression of Chr9p21 genes CDKN2B (p15INK4b), CDKN2A (p16INK4a, 14ARF). and MTAP in human atherosclerotic plaque. Atherosclerosis 214, 264-270 (2011
95. Ihling, C. et al. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb. Vasc. Biol. 17, 2218-2224 (1997
96. Gonzalez-Navarro, H. et al. p19ARF deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J. Am. Coll. Cardiol 55, 2258-2268 (2010
97. Mercer, J., Figg, N., Stoneman, V., Braganza, D. & Bennett, M. R. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ. Res. 96, 667-674 (2005
98. Mercer, J. & Bennett, M. The role of p53 in atherosclerosis. Cell Cycle 5, 1907-1909 (2006
99. Khanna, A. K. Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis. J. Biomed. Sci. 16, 66 (2009
100. Diez-Juan, A. & Andres, V. The growth suppressor p27Kip1 protects against diet-induced atherosclerosis. FASEB J. 15, 1989-1995 (2001
101. Sanz-Gonzalez, S. M. et al. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis. Cardiovasc. Res. 75, 803-812 (2007
102. Hayashi, T. et al. Endothelial cellular senescence is inhibited by liver X receptor activation with an additional mechanism for its atheroprotection in diabetes. Proc. Natl Acad. Sci. USA 111, 1168-1173 (2014
103. Sharpless, N. E. & DePinho, R. A. How stem cells age and why this makes us grow old. Nature Rev. Mol. Cell Biol. 8, 703-713 (2007
104. Jeck, W. R., Siebold, A. P. & Sharpless, N. E. Review: A meta-Analysis of GWAS and age-Associated diseases. Aging Cell 11, 727-731 (2012
105. Liu, Y. et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS ONE 4, e5027 (2009
106. Visel, A. et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409-412 (2010
107. Kuo, C. L. et al. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arterioscler Thromb. Vasc. Biol. 31, 2483-2492 (2011
108. Noureddine, H. et al. Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ. Res. 109, 543-553 (2011
109. Mizuno, S. et al. p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L753-761 (2011
110. Mouraret, N. et al. Activation of lung p53 by Nutlin-3a prevents and reverses experimental pulmonary hypertension. Circulation 127, 1664-1676 (2013
111. Geiger, H., De Haan, G. & Florian, M. C. The ageing haematopoietic stem cell compartment. Nature Rev. Immunol. 13, 376-389 (2013
112. Alder, J. K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 105, 13051-13056 (2008
113. Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317-1326 (2007
114. Chilosi, M., Carloni, A., Rossi, A. & Poletti, V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl. Res. 162, 156-173 (2013
115. Aoshiba, K., Tsuji, T. & Nagai, A. Bleomycin induces cellular senescence in alveolar epithelial cells. Eur. Respir. J. 22, 436-443 (2003
116. Aoshiba, K. et al. Senescence-Associated secretory phenotype in a mouse model of bleomycin-induced lung injury. Exp. Toxicol. Pathol. 65, 1053-1062 (2013
117. Minagawa, S. et al. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L391-401 (2011
118. Hecker, L. et al. Reversal of persistent fibrosis in aging by targeting nox4-nrf2 redox imbalance. Sci. Transl Med. 6, 231ra47 (2014
119. Shivshankar, P. et al. Caveolin-1 deficiency protects from pulmonary fibrosis by modulating epithelial cell senescence in mice. Am. J. Respir. Cell. Mol. Biol. 47, 28-36 (2012
120. Lv, X. X. et al. Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents. PLoS ONE 8, e68631 (2013
121. Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445 (2011
122. Minamino, T. et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nature Med. 15, 1082-1087 (2009
123. Tchkonia, T. et al. Fat tissue, aging, and cellular senescence. Aging Cell 9, 667-684 (2010
124. Markowski, D. N. et al. HMGA2 expression in white adipose tissue linking cellular senescence with diabetes. Genes Nutr. 8, 449-456 (2013
125. Baker, D. J. et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nature Cell Biol. 10, 825-836 (2008
126. Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-Associated disorders. Nature 479, 232-236 (2011
127. Donath, M. Y., Dalmas, E., Sauter, N. S. & Boni-Schnetzler, M. Inflammation in obesity and diabetes: Islet dysfunction and therapeutic opportunity. Cell. Metab. 17, 860-872 (2013
128. Sone, H. & Kagawa, Y. Pancreatic β cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48, 58-67 (2005
129. Wang, Z., Moro, E., Kovacs, K., Yu, R. & Melmed, S. Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc. Natl Acad. Sci. USA 100, 3428-3432 (2003
130. Chesnokova, V. et al. Diminished pancreatic β-cell mass in securin-null mice is caused by β-cell apoptosis and senescence. Endocrinology 150, 2603-2610 (2009
131. Campaner, S. et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nature Cell Biol. 12, 54-59 (2010
132. Tavana, O., Puebla-Osorio, N., Sang, M. & Zhu, C. Absence of p53-dependent apoptosis combined with nonhomologous end-joining deficiency leads to a severe diabetic phenotype in mice. Diabetes 59, 135-142 (2010
133. Tavana, O. & Zhu, C. Too many breaks (brakes): Pancreatic β-cell senescence leads to diabetes. Cell Cycle 10, 2471-2484 (2011
134. Doria, A., Patti, M. E. & Kahn, C. R. The emerging genetic architecture of type 2 diabetes. Cell. Metab. 8, 186-200 (2008
135. Krishnamurthy, J. et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453-457 (2006
136. Gonzalez-Navarro, H. et al. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging. Aging Cell 12, 102-111 (2013
137. Sousa-Victor, P. et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506, 316-321 (2014
138. Cosgrove, B. D. et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nature Med. 20, 255-264 (2014
139. Du, J. et al. Aging increases CCN1 expression leading to muscle senescence. Am. J. Physiol. Cell Physiol. 306, C28-36 (2014
140. Bernet, J. D. et al. p38 MAPK signaling underlies a cell-Autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nature Med. 20, 265-271 (2014
141. Iglesias-Bartolome, R. et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 11, 401-414 (2012
142. Wei, H. et al. Changes and function of circulating endothelial progenitor cells in patients with cerebral aneurysm. J. Neurosci. Res. 89, 1822-1828 (2011
143. Fukazawa, R. et al. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circ. J. 71, 709-715 (2007
144. Yasuno, K. et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nature Genet. 42, 420-425 (2010
145. Golledge, J. & Kuivaniemi, H. Genetics of abdominal aortic aneurysm. Curr. Opin. Cardiol 28, 290-296 (2013
146. Liton, P. B. et al. Cellular senescence in the glaucomatous outflow pathway. Exp. Gerontol. 40, 745-748 (2005
147. Ozel, A. B. et al. Genome-wide association study and meta-Analysis of intraocular pressure. Hum. Genet. 133, 41-57 (2014
148. Ng, S. K., Casson, R. J., Burdon, K. P. & Craig, J. E. Chromosome 9p21 primary open-Angle glaucoma susceptibility locus: A review. Clin. Experiment Ophthalmol. 42, 25-32 (2014
149. Bhat, R. et al. Astrocyte senescence as a component of Alzheimer's disease. PLoS ONE 7, e45069 (2012
150. Chinta, S. J. et al. Environmental stress, ageing and glial cell senescence: A novel mechanistic link to Parkinson's disease? J. Intern. Med. 273, 429-436 (2013
151. Hamshere, M. L. et al. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease. Hum. Mol. Genet. 16, 2703-2712 (2007
152. Zuchner, S. et al. Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. Ann. Hum. Genet. 72, 725-731 (2008
153. Fischer, B. M. et al. Increased expression of senescence markers in cystic fibrosis airways. Am. J. Physiol. Lung Cell. Mol. Physiol. 304, L394-400 (2013
154. Sohn, J. J. et al. Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease. PLoS ONE 7, e44156 (2012
155. Martin, J. A., Brown, T. D., Heiner, A. D. & Buckwalter, J. A. Chondrocyte senescence, joint loading and osteoarthritis. Clin. Orthop. Relat. Res. 427, S96-103 (2004
156. Price, J. S. et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1, 57-65 (2002
157. Roberts, S., Evans, E. H., Kletsas, D., Jaffray, D. C. & Eisenstein, S. M. Senescence in human intervertebral discs. Eur. Spine J. 15 (Suppl. 3), S312-316 (2006
158. Le Maitre, C. L., Freemont, A. J. & Hoyland, J. A. Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res. Ther. 9, R45 (2007
159. Mishima, K. et al. Senescence-Associated β-galactosidase histochemistry for the primate eye. Invest. Ophthalmol. Vis. Sci. 40, 1590-1593 (1999
160. Zhu, D., Wu, J., Spee, C., Ryan, S. J. & Hinton, D. R. BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J. Biol. Chem. 284, 9529-9539 (2009
161. Salazar, L. M. & Herrera, A. M. Fibrotic response of tissue remodeling in COPD. Lung 189, 101-109 (2011
162. Tsuji, T., Aoshiba, K. & Nagai, A. Cigarette smoke induces senescence in alveolar epithelial cells. Am. J. Respir. Cell. Mol. Biol. 31, 643-649 (2004
163. Tsuji, T., Aoshiba, K. & Nagai, A. Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration 80, 59-70 (2010
164. Fitzner, B. et al. Senescence determines the fate of activated rat pancreatic stellate cells. J. Cell. Mol. Med. 16, 2620-2630 (2012
165. Michaloglou, C. et al. BRAFE600-Associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724 (2005
166. Nardella, C., Clohessy, J. G., Alimonti, A. & Pandolfi, P. P. Pro-senescence therapy for cancer treatment. Nature Rev. Cancer 11, 503-511 (2011
167. Collado, M. & Serrano, M. The power and the promise of oncogene-induced senescence markers. Nature Rev. Cancer 6, 472-476 (2006
168. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995
169. Kurz, D. J., Decary, S., Hong, Y. & Erusalimsky, J. D. Senescence-Associated β-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 113, 3613-3622 (2000
170. Young, A. R. et al. Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798-803 (2009
171. Georgakopoulou, E. A. et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging 5, 37-50 (2013
172. Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003
173. Zhang, R. et al. Formation of MacroH2A-containing senescence-Associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8, 19-30 (2005
174. Di Micco, R. et al. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nature Cell Biol. 13, 292-302 (2011
175. Scaffidi, P. & Misteli, T. Lamin A-dependent nuclear defects in human aging. Science 312, 1059-1063 (2006
176. Collado, M. et al. Tumour biology: Senescence in premalignant tumours. Nature 436, 642 (2005
177. Shimi, T. et al. The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev. 25, 2579-2593 (2011
178. Freund, A., Laberge, R. M., Demaria, M. & Campisi, J. Lamin B1 loss is a senescence-Associated biomarker. Mol. Biol. Cell 23, 2066-2075 (2012
179. Herbig, U., Ferreira, M., Condel, L., Carey, D. & Sedivy, J. M. Cellular senescence in aging primates. Science 311, 1257 (2006
180. Wang, C. et al. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8, 311-323 (2009
181. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194-1217 (2013
182. Freund, A., Orjalo, A. V., Desprez, P. Y. & Campisi, J. Inflammatory networks during cellular senescence: Causes and consequences. Trends Mol. Med. 16, 238-246 (2010
183. Naylor, R. M., Baker, D. J. & van Deursen, J. M. Senescent cells: A novel therapeutic target for aging and age-related diseases. Clin. Pharmacol. Ther. 93, 105-116 (2013
184. Campisi, J. Aging, tumor suppression and cancer: High wire-Act! Mech. Ageing Dev. 126, 51-58 (2005
185. Rajagopalan, S. & Long, E. O. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl Acad. Sci. USA 109, 20596-20601 (2012
186. Dorr, J. R. et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 501, 421-425 (2013